Trial · NCT00311571
Registered outcomes24
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 24
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Muscle size and function | ||
| Primary | Muscle protein composition, muscle fiber type composition andmuscle enzyme content of soleus and vastus lateralis muscles | ||
| Primary | Bone mineral content and structure | ||
| Primary | Isokinetic muscle strength (using Cybex) | ||
| Primary | Fluid volume shift | ||
| Primary | Calcium metabolism and hormonal control | ||
| Primary | Sleep assessment by questionnaires and actigraphy | ||
| Primary | RR interval from an ECG lead signal by an high impedance probe, Systolic (SAP), Diastolic (DAP) and Mean arterial pressure (MAP) by Finapres (or Portapres) andRespiration by a piezoelectric pneumobelt, | ||
| Primary | Acetaminophen pharmacokinetic parameters, | ||
| Primary | 24 h profile of spine geometry,flexibility index of spine, activity of lower back muscles, | ||
| Primary | and subjective rating of back pain | ||
| Primary | Maximal oxygen consumption. | ||
| Primary | Cardiovascular oxygen transport (oxygen delivery and oxygen return), requiring measurement of cardiac output, heart rate, arterialized blood gas composition, and arterial oxygen saturation. | ||
| Primary | Gas exchange kinetics at the onset and offset of exercise, requiring measurement of breath-by-breath ventilation and expired gas composition. | ||
| Primary | Blood volume | ||
| Primary | Plasma concentrations of arginin vasopressin, atrial natriuretic peptide, renin, endothelin, cyclic GMP and catecholamines. Urine concentrations of catecholamines, arginin vasopressin and cyclic GMP Blood concentration of nitric oxide. | ||
| Primary | Total energy expenditure, Lipid metabolism, body composition, water turnover and the formation of metabolic water. | ||
| Primary | Heart rate variability and post-ganglionic sympathetic nerve activity. | ||
| Primary | Arterial cardiac chronotropic baroreflex sensitivity and ventricular interdependence. | ||
| Primary | Ventricular mass and cardiac dimension. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00311571/registered